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Summary
Objective: The aim of this study was to determine if children exposed
to environmental tobacco smoke (ETS) via parental smoking (ETS+)
developed more respiratory symptoms resulting in longer recovery
times following surgical outpatient procedures compared with chil-
dren of nonsmoking parents (ETS)).
Methods: One hundred and forty six children (4.9 ± 3 years) under-
going inguinal hernia repair were prospectively studied. Parental
smoking behaviour was determined by survey and urine analysis.
Seven respiratory symptoms were evaluated during induction and
emergence from anaesthesia and during the recovery room (RR) stay.
Results: Fifty-seven (39%) families admitted a smoking history while
89 (61%) denied it. This strongly correlated with the cotinine/
creatinine ratio (Pearson correlation coefficient ¼ 0.76; P ¼ 0.01). ETS
exposure was associated with an increased frequency of RR symptoms
(ETS+: 56%; ETS): 31%; P ¼ 0.007).
Conclusions: In children undergoing general anaesthesia for inguinal
hernia repair, ETS exposure was associated with an increased
frequency of respiratory symptoms during emergence from anaes-
thesia and during postoperative recovery.
Keywords: environmental tobacco smoke; cotinine; respiratory
symptoms
Introduction
Numerous reports have shown that environmental
tobacco smoke (ETS), commonly referred to as
second-hand smoke, is deleterious to the health of
foetuses, infants and children. Passive and active
smoking by pregnant mothers has been shown to
lower neonatal birth weights (1–3) and result in a
higher incidence of neonatal mortality (4). In addi-
tion, children of smoking mothers also have a higher
incidence of respiratory disorders, reduced rate of
lung function development, deficiencies in physical
growth, as well as delays in intellectual and
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emotional development (4–9). The onset of child-
hood asthma has been associated with exposure to
passive smoking (10,11); however, other papers
argue against this association (12,13). Additionally,
second-hand smoke has been shown to act as a
major trigger for exacerbation of children’s asthma
(14–16) and is associated with increased asthma
severity in adulthood (17,18). Other papers suggest
that in utero smoke exposure is associated with
wheezing and physician-diagnosed asthma, but not
postnatal ETS exposure (19–22). Second-hand smoke
increases asthma symptoms (23), bronchial hyper-
activity (24), trips to the emergency department
(25,26), and medication usage (23,25).
Tobacco smoking is known to pose risks to adult
patients who undergo general anaesthesia. These
include disruption of myocardial oxygen balance,
high carbon monoxide exposure leads to high
carboxyhaemoglobin levels which may affect pulse
oximetry, and increased postoperative mortality
secondary to respiratory complications compared
with nonsmokers (27–30). In addition, smokers
experience increased length of stay in postanaesthe-
sia care units (PACU), and require longer anaes-
thetic times (AT) than nonsmokers. All of these
effects have been correlated with the number of
cigarettes smoked per day (31).
Cotinine, the major metabolite of nicotine, is
tobacco specific with a half-life of approximately
24 h, making it a useful marker to assess an indi-
vidual’s recent level of exposure to ETS (32). Coti-
nine can be measured in serum, saliva or in urine.
Importantly, numerous investigators have correlated
ETS exposure and levels of urinary cotinine in both
adults and children (33–38). Urinary cotinine levels
in children correlate with parental smoking as well
as with the number of cigarettes consumed per day
in the household environment (39,40).
The effects of second-hand smoke on children
undergoing general anaesthesia has not been conclu-
sively determined. There is evidence that both pre-
and postnatal ETS exposure may impact respiratory
function, especially lung development; and, thus,
these patients may be more susceptible to adverse
side-effects following anaesthesia than nonexposed
children (8,9,41,42). We hypothesized that the degree
of ETS exposure in children as a result of parental
smoking, measured using urinary cotinine as a
marker, results in an increase in perioperative respir-
atory complications following general anaesthesia for
inguinal hernia repair, and that these complications
result in an increase in total recovery room (RR) time.
Materials and methods
Following approval from University of Michigan’s
Institutional Review Board and written informed
parental consent, 146 children (4.9 ± 3.2 years)
undergoing elective inguinal hernia repair under
general anaesthesia (GA) between 1997 and 1999
were prospectively studied. Children scheduled for
elective inguinal hernia repair from 3 months to
13 years of age were eligible for entry into the study.
Exclusion criteria included children with a history of
renal failure, diabetes insipidus, diabetes mellitus,
cyanotic heart disease, incarcerated hernias or chil-
dren less than 37 weeks of gestational age at birth.
Urine samples were obtained from parents and
patients for measurement of cotinine and creatinine
levels. In addition, data regarding the method of
anaesthetic delivery, surgical duration, adverse res-
piratory events during induction and emergence
from anaesthesia and during the recovery room stay,
duration of the postanaesthesia care unit stay, intra-
and postoperative pain medications, parental smo-
king habits (by survey) and physiological criteria for
patient discharge were collected.
All patients underwent general anaesthesia
according to the following protocol: children
were premedicated with midazolam intranasally
(0.2 mgÆkg)1) or orally (0.5 mgÆkg)1). Following an
inhalation induction of anaesthesia with halothane,
an intravenous catheter was placed followed by
administration of atracurium (0.5 mgÆkg)1). Anaes-
thesia was maintained with 0.5–1.0 MAC1 isoflurane in
70% nitrous oxide and 30% oxygen. Following
induction and prior to skin incision, acetaminophen
(20 mgÆkg)1) was administered. At this time, addi-
tional analgesic measures included either an ilio-
inguinal nerve block using 0.25% bupivacaine
(0.25 mlÆkg)1, maximum 5 ml) or a caudal block using
0.25% bupivacaine (0.5–0.75 mlÆkg)1, maximum
15 ml) with 1 : 200 000 epinephrine (0.75 mlÆkg)1,
maximum 15 ml). In addition, prior to skin closure,
the wound was infiltrated with 0.25% bupivacaine. In
the RR, patients received incremental doses of mor-
phine sulphate for breakthrough pain (up to a maxi-
mum of 0.1 mgÆkg)1) intravenously. Ondansetron
ENVIRONMENTAL TOBACCO SMOKE IN CHILDREN 305
 2003 Blackwell Publishing Ltd, Paediatric Anaesthesia, 13, 304–310
(0.15 mgÆkg)1, maximum 4 mg) was administered to
treat postoperative nausea and vomiting.
On the day of surgery, a urine sample was
obtained from the child and both parents. The urine
sample was then frozen and stored in a )70C
freezer for later analysis of cotinine, nicotine and
creatinine. Parental cotinine was measured by a
spectrophotometric assay previously described and
was able to accurately discriminate smokers from
nonsmokers (43). Patient cotinine and nicotine levels
were measured by a more sensitive method using
high-pressure liquid chromatography (44). Parental
and patient creatinine levels were measured spectro-
photometrically by a standard diagnostic kit (2 Sigma
555). Concentrations of cotinine were expressed as
nanogram urine cotinine/mg urine creatinine,
termed the cotinine–creatinine ratio (CCR).
Parents were asked to fill out a questionnaire
designed to elicit information on their smoking
habits and the exposure of their children to sec-
ond-hand smoke. Neither the anaesthesiologists nor
the RR nurses were aware of parental smoking
status. The anaesthesiologist evaluated the child
during induction of and emergence from GA for
seven airway and cardiopulmonary criteria inclu-
ding: coughing (>15 s), laryngospasm (active glottic
closure requiring intervention), inspiratory or expir-
atory stridor, excessive salivation, breath holding
(>10 s), bradycardia (50% reduction of baseline
heart rate) and wheezing. The RR nurses also
monitored these same parameters until the patient
was transferred to the step-down RR or discharged.
An additional recovery room survey instrument
measured the time that the patient achieved physio-
logical readiness to be transferred from the main RR
to the step-down RR; that time was recorded and
designated as the recovery room stay. This was
carried out in order to remove ‘noise’ inherent in the
system which delays patient discharge such as nurse
staffing problems, physician availability in signing
discharge orders or parental delay in obtaining and
understanding discharge instructions.
Data were analysed using an SPSS statistical
package with a P-value of <0.05 considered
significant. Student’s t-test was used to compare
the continuous data and the chi-square test was used
to evaluate categorical data. Logistic regression with
multivariable analysis of the study parameters was
utilized to identify predictive variables. Data are
represented as mean ± SD, median and range, unless
otherwise noted.
Results
Analysis of smoke exposed (ETS+) and nonexposed
(ETS)) patient demographics are presented in
Table 1. There was no significant difference in mean
patient age, mean total operative time or the mean
total time the patients spent in the PACU. Patient
weight was significantly different between the two
groups (P ¼ 0.001). There was no significant differ-
ence between the percentage of males and females
who were smoke exposed by survey (P ¼ 0.68).
Likewise, there were no significant differences in
type of anaesthetic regimen employed between the
two groups (P ¼ 0.46).
Parent demographic data are presented in Table 2.
Correlation between survey results and parental
urine CCR analysis was highly significant (Pearson
correlation coefficient ¼ 0.76; P < 0.01). Fathers who
smoked comprized 34% (n ¼ 49) of the population
studied and were younger, but not significantly,
than nonsmoking fathers (34.6 ± 8.6 years vs










Males 69 (60%) 46 (40%)
Females 20 (65.5%) 11 (35.5%) 0.68
Anaesthetic regimen
Caudal block 65 (63%) 38 (37%)
Inguinal block 24 (56%) 19 (44%) 0.46
Patient age (years)




Mean ± SD 19.2 ± 8.4 22.6 ± 16.1 0.001
Median 18 18.9
Range 5.8–51 4.8–79
Total operative time (min)
Mean ± SD 43.4 ± 16.2 47.2 ± 24.1 0.30
Median 39 42
Range 21–103 20–178
Total recovery room time (min)
Mean ± SD 116 ± 52 111 ± 48 0.66
Median 102 100
Range 45–367 57–335
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smoked an average of 17.7 ± 12.0 cigarettes per day,
and they had mean urine CCR of 13 858 ± 7464
(nanogram cotinine/mg creatinine), which was
significantly higher than the CCR of fathers who
were nonsmokers (1566 ± 1369 ngÆmg)1); P ¼ 0.001).
Mothers who smoked comprised 28% (n ¼ 41) of
the population studied, however, in contrast with
fathers, were significantly younger (30.9 ± 6.5 years
old) compared with nonsmoking mothers (34.8 ±
6.2 years old; P ¼ 0.001). Mothers smoked an
average of 11.8 ± 9.6 cigarettes per day, and had
significantly increased mean urine CCR of
13 230 ± 10 538 ngÆmg)1; P ¼ 0.001) compared with
nonsmoking mothers (1966 ± 1541 ngÆmg)1. When
either or both parents smoked, the children were
designated as smoke exposed (ETS+) and consisted
of 39% (n ¼ 57) of the population studied. The mean
urine CCR of the tobacco smoking parental group
was 13 680 ± 7832 ngÆmg)1 (vs 1797 ± 1398 ngÆmg)1
in nonsmoking households; P ¼ 0.001) and the mean
number of cigarettes smoked was 27.2 ± 18.4 per day.
Mean nicotine level was 16.2 ± 34.6 ngÆml)1 in
the smoke exposed children vs. 6.4 ± 10.6 ngÆml)1
in those children whose parents did not smoke
(P ¼ 0.022). Likewise, the mean level of the nico-
tine metabolite, cotinine, in smoke exposed chil-
dren was significantly elevated compared with
children whose parents did not smoke (11.7 ± 21.0
vs 1.0 ± 5.2 ngÆml)1, respectively) (P ¼ 0.001). The
mean CCR was also significantly elevated (17.6 ±
29.4 ngÆmg)1 vs 1.5 ± 7.4 ngÆmg)1) (P ¼ 0.001) in
smoke exposed children (Table 3).
The frequency of respiratory symptoms is presen-
ted in Table 4. For all patients in the study, the
frequency of any respiratory symptom occurring
during induction, emergence and in the recovery
room was 14.3%, 41.7% and 40.9%, respectively.
There was a significant increase in the frequency of
recovery room symptoms in the ETS+ children
(56%) compared with those not exposed (31%;
P < 0.01). Recovery room time between ETS exposed
children and nonexposed children was not signifi-
cantly different (ETS+ 111 ± 48 min vs ETS)







(n, % ) P-value
Father (n, %) 93 (66%) 49 (34%) 0.001
Mother (n, %) 104 (72%) 41 (28%) 0.001
Either parent (n, %) 89 (61%) 57 (39%) 0.001
Father age (years)
Mean ± SD 36.8 ± 7.0 34.6 ± 8.6 0.085
Median (range) 36 (22–57) 34 (18–59)
Mother age (years)
Mean ± SD 34.8 ± 6.2 30.9 ± 6.5 0.001
Median (range) 35 (20–52) 31 (17–50)
Father cotinine–creatinine ratio (CCR) (ngÆmg)1)
Mean ± SD 1566 ± 1369 13 858 ± 7464 0.001
Median (range) 1135 (304–7655) 13 992 (1264–29 708)
Mother CCR (ngÆmg)1)
Mean ± SD 1966 ± 1541 13 230 ± 10 538 0.001
Median 1535 (57–9441) 11 366 (824–42 947)
Father (cigarettes per day; survey)
Mean ± SD 0 17.7 ± 12.0 0.001
Median (range) 0 (0) 20 (0.5–60)
Mother (cigarettes per day; survey)
Mean ± SD 0 11.8 ± 9.6 0.001
Median (range) 0 (0) 10 (0.5–30)
Total parent CCR (ngÆmg)1)
Mean ± SD 1797 ± 1398 13 680 ± 7832 0.001
Median (range) 1513 (204–8000) 12 320 (1264–31 695)
Total parent (cigarettes per day)
Mean ± SD 0 27.2 ± 18.4 0.001
Median (range) 0 (0) 25 (0.5–80)
Table 3
Urinary nicotine, cotinine and cotinine–creatinine ratio (CCR)
levels in patients
Variable ETS+ ETS) P-value
Nicotine (ngÆml)1)












Frequency of respiratory events in patients during induction and








All patients 14 (20) 42 (58) 41 (54)
ETS+ 13 (7) 44 (25) 56 (30)*
ETS) 16 (13) 40 (33) 31 (24)
*P < 0.01 compared with ETS).
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The frequency of specific symptoms found in the
recovery room between ETS+ and ETS) children is
presented in Figure 1. Coughing (42.6 vs 25.6%) and
breath holding (18.5 vs 5.1%) in the RR was
significantly increased in ETS+ children compared
with the ETS) children (P < 0.05). All of the other
individual variables evaluated trended higher in
ETS+ patients compared with ETS) patients, but the
differences were not statistically significant. How-
ever, the prevalence of having any recovery room
respiratory symptom was significantly higher in the
ETS+ patients (56%) compared with ETS) patients
(31%; P ¼ 0.007).
The presence of respiratory symptoms in the
recovery room was highly correlated with ETS
exposure by smoking parents (P ¼ 0.0039) and total
anaesthetic time (P ¼ 0.0342), based on logistic
regression. Further logistic regression analysis indi-
cated a significant correlation between parental
smoking and their child’s CCR levels (P ¼ 0.0018).
Lastly, patient CCR levels were highly correlated
(P ¼ 0.01) with the mean number of cigarettes
smoked per day by both parents (Pearson correla-
tion ¼ 0.61), mean number of cigarettes smoked per
day by the mother (Pearson correlation ¼ 0.557) and
the mean number cigarettes smoked per day by the
father (Pearson correlation ¼ 0.554).
Discussion
Environmental tobacco smoke is a by-product of
cigarette smoking, consisting of sidestream smoke
(produced by burning tobacco) and exhaled smoke
processed through a primary smokers’ lung. Over
3800 compounds have been identified in tobacco
smoke (45), and most ETS exposure is from unfil-
tered sidestream smoke, i.e. that not filtered through
the cigarette or processed by a primary smokers’
lungs. There is empirical evidence that sidestream
smoke (which contains high concentrations of
ammonia, benzene, nicotine, carbon monoxide and
many carcinogens) is more deleterious to health
because it is not filtered through either the cigarette
or the smoker (46–57). Cotinine, a nicotine meta-
bolite with a half-life of about 1 day, has been found
in hair, saliva, blood and urine of both primary
smokers as well as that of nonsmokers exposed to
ETS. Smoke exposed children may be more suscept-
ible than adults to the deleterious effects of second-
hand smoke because of their smaller size, stage of
development and maturation.
In adult patients undergoing general anaesthesia,
disruption of myocardial oxygen balance, high
carbon monoxide haemoglobin levels, increased
postoperative mortality secondary to respiratory
complications, increased length of stay in PACU
and requirements of longer anaesthetic times (AT)
than in nonsmokers have been reported (27–31).
These effects correlate with the degree of smoking as
well as the number of cigarettes consumed per day.
Our study confirmed that there is a significant
correlation between the presence and amount of
parental cigarette smoking and a child’s CCR levels.
Significantly higher levels of urinary nicotine and
cotinine were observed in children of smoking
parents compared with children of nonsmokers.
Furthermore, children’s CCR levels were most
highly correlated with both the mother and father’s
smoking behaviour. This is similar to a report by
Oddoze et al., who analysed urinary cotinine levels,
and documented a high correlation between the
number of cigarettes smoked, especially by the
mother, and children’s urinary cotinine levels (58).
Skolnick reported an increase in airway complica-
tions of smoke exposed children receiving general
anaesthesia (59). These authors stratified patients
based upon urine cotinine and noted an association
between smoke exposure and airway complications.
In our study, the frequency of respiratory complica-
tions during anaesthetic induction was comparable
in ETS+ vs ETS) patients. However, during emer-


















Distribution of recovery room symptoms in environmental
tobacco smoke (ETS+) and ETS) children postoperatively. There
was a significant difference in the frequency of breath holding and
coughing, as well as differences in the frequency of exhibiting any
respiratory symptom in the recovery room between smoke
exposed and nonsmoke exposed children.
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gence from anaesthesia and while the patients were
in the recovery room, an increased frequency of
respiratory complications was noted in all patients.
Our analysis documented a further increase in the
frequency of respiratory symptoms during the RR
stay in the smoke exposed population (56%) com-
pared with the nonsmoke exposed population (31%;
P < 0.01). However, the total RR time between ETS+
and ETS) children was similar.
Both pre- and postnatal ETS exposure may have an
impact on respiratory function, especially lung
development (8,9,41,42). Newborns exposed to pre-
natal smoke exposure have a higher arousal thresh-
old to auditory stimuli (60). Prenatal smoke exposure
has likewise been correlated with an increase in
frequency and length of obstructive sleep apnoea
(61), and with changes in autonomic nervous system
control and subsequent maturation in infants (62). It
is unknown whether prenatal or postnatal ETS
exposure has a greater effect on subsequent lung
growth and respiratory function. Most mothers who
smoke during pregnancy continue smoking after
their child is born, making studies of this problem
difficult to conduct. In addition, mothers who do not
smoke prior to and during pregnancy, infrequently
take up the habit postdelivery, an important study
group for answering questions regarding the impact
of prenatal vs postnatal smoke exposure upon
respiratory function.
Our study was not designed to discriminate the
effects of prenatal vs postnatal smoke exposure.
Available evidence suggests a deleterious role by
both prenatal and postnatal smoke exposure on lung
development and respiratory function. Our study
documents a significant association between paren-
tal smoking and patient CCR levels, a physiological
measure of smoke exposure, and postoperative
respiratory symptoms following inguinal hernia
surgery in children.
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